Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer_journal/leukemic-mantle-cell-lymphoma-and-chronic-lymphocytic-leukemia-a-rare-9emSmTEF40
References (14)
-
Michael Wang, S. Rule, P. Martin, A. Goy, R. Auer, B. Kahl, W. Jurczak, R. Advani, J. Romaguera, Michael Williams, J. Barrientos, E. Chmielowska, J. Radford, S. Stilgenbauer, M. Dreyling, W. Jędrzejczak, Peter Johnson, S. Spurgeon, Lei Li, L. Zhang, K. Newberry, Zhishuo Ou, N. Cheng, B. Fang, J. Mcgreivy, F. Clow, J. Buggy, B. Chang, D. Beaupre, L. Kunkel, K. Blum (2013)
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.The New England journal of medicine, 369 6
-
Yi Sun, Sa Wang, T. Sun (2018)
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphomaCytometry Part B: Clinical Cytometry, 94
-
Michael Wang, S. Rule, P. Zinzani, A. Goy, O. Casasnovas, Stephen Smith, G. Damaj, J. Doorduijn, T. Lamy, F. Morschhauser, C. Panizo, B. Shah, A. Davies, A. Davies, R. Eek, J. Dupuis, E. Jacobsen, A. Kater, S. Gouill, L. Obéric, Taduesz Robak, T. Covey, R. Dua, A. Hamdy, Xin Huang, R. Izumi, P. Patel, Wayne Rothbaum, J. Slatter, W. Jurczak (2017)
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trialThe Lancet, 391
-
I. Schliemann, I. Oschlies, I. Nagel, Eva Penas, R. Siebert, B. Sander (2016)
The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemiaLeukemia & Lymphoma, 57
-
F. Fend, L. Quintanilla‐Martinez, Shimareet Kumar, M. Beaty, Loryn Blum, L. Sorbara, E. Jaffe, M. Raffeld (1999)
Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.The American journal of pathology, 154 6
-
M. Hallek (2017)
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatmentAmerican Journal of Hematology, 92
-
S. Hoeller, Yi Zhou, R. Kanagal-Shamanna, Z. Xu-Monette, D. Hoehn, M. Bihl, S. Swerdlow, A. Rosenwald, G. Ott, J. Said, C. Dunphy, C. Bueso-Ramos, P. Lin, Michael Wang, R. Miranda, A. Tzankov, L. Medeiros, K. Young (2013)
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.Human pathology, 44 1
-
Lina Nygren, Stefanie Wennerholm, Monika Klimkowska, B. Christensson, E. Kimby, B. Sander (2012)
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.Blood, 119 18
-
R. Küppers, U. Dührsen, M. Hansmann (2014)
Pathogenesis, diagnosis, and treatment of composite lymphomas.The Lancet. Oncology, 15 10
-
S. Ondrejka, R. Lai, Stephen Smith, E. Hsi (2011)
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosisHaematologica, 96
-
Z. Hu, Yi Sun, E. Schlette, G. Tang, Shaoying Li, Jie Xu, C. Yin, Ken Young, K. Patel, Roberto Miranda, Maitrayee Goswami, Michael Wang, J. Jorgensen, L. Medeiros, Sa Wang (2018)
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseModern Pathology, 31
-
B. Sander, L. Quintanilla‐Martinez, G. Ott, L. Xerri, I. Kuzu, J. Chan, S. Swerdlow, E. Campo (2016)
Mantle cell lymphoma—a spectrum from indolent to aggressive diseaseVirchows Archiv, 468
-
W. Kern, U. Bacher, S. Schnittger, F. Dicker, T. Alpermann, T. Haferlach, C. Haferlach (2014)
Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B‐CLL) and its genetic characterizationBritish Journal of Haematology, 164
-
T. Kourelis, B. Kahl, P. Benn, J. Delach, S. Bilgrami (2011)
Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and RituximabActa Haematologica, 126
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
- Subject
- Medicine & Public Health; Pathology; Hematology
- ISSN
- 1868-9256
- eISSN
- 1865-5785
- DOI
- 10.1007/s12308-018-0321-7
- Publisher site
- See Article on Publisher Site
Abstract
Composite lymphomas are rare entities that either represent a collision of two separate lymphomas, or one lymphoma that expresses two distinct phenotypes. Mantle cell lymphoma has been reported in some composite lymphomas, but when combined with chronic lymphocytic leukemia, it can be difficult to recognize because of the phenotypic overlap of these two entities. We report a case of a 75-year-old male with a slowly progressing lymphocytosis, but who was otherwise asymptomatic. Flow cytometry revealed two different populations, one showing bright Lambda positivity and CD5(+), while the other was positive for both lambda and kappa and was CD5(+). Subsequently, cytogenetics revealed two different populations, one with a trisomy 12 and the other with a t(11;14). Additionally, immunohistochemistry on a bone marrow biopsy showed SOX-11 to be negative and cyclin D1 to be positive on scattered lymphocytes. This was consistent with a composite lymphoma of leukemic mantle cell lymphoma and chronic lymphocytic lymphoma.
Journal
Journal of Hematopathology – Springer Journals
Published: Apr 4, 2018